These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2509709)

  • 41. Different effects of two aldose reductase inhibitors on nociception and prostaglandin E.
    Calcutt NA; Li L; Yaksh TL; Malmberg AB
    Eur J Pharmacol; 1995 Oct; 285(2):189-97. PubMed ID: 8566138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of aldose reductase inhibitors by determination of IC50 with bovine and rat lens extracts.
    Müller P; Hockwin O; Ohrloff C
    Ophthalmic Res; 1985; 17(2):115-9. PubMed ID: 3920598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aminoguanidine does not inhibit aldose reductase activity in galactose-fed rats.
    Dvornik D; Hohman TC; Basso MD
    J Diabetes Complications; 1996; 10(1):23-30. PubMed ID: 8639971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Diabetic changes in pupillary reaction and iridal pathology. No. 1. The role of aldose reductase to the delayed pupillary reaction in galactose-fed rats].
    Terubayashi H; Akagi Y; Kador PF; Kinoshita JH
    Nippon Ganka Gakkai Zasshi; 1988 Mar; 92(3):484-8. PubMed ID: 3137794
    [No Abstract]   [Full Text] [Related]  

  • 45. Isoxazolidine-3,5-diones as lens aldose reductase inhibitors.
    Richon AB; Maragoudakis ME; Wasvary JS
    J Med Chem; 1982 Jun; 25(6):745-7. PubMed ID: 6808134
    [No Abstract]   [Full Text] [Related]  

  • 46. In vitro inhibition of glucose phosphorylation by an aldose-reductase inhibitor (Tolrestat) in some non-insulin-sensitive rabbit tissues.
    Iannello S; Cavaleri A; Camuto M; Belfiore F
    J Diabetes Complications; 1999; 13(2):68-73. PubMed ID: 10432169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathogenesis of diabetic neuropathy--do hyperglycemia and aldose reductase inhibitors affect neuroactive steroid formation in the rat sciatic nerves?
    Colciago A; Negri-Cesi P; Celotti F
    Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):22-6. PubMed ID: 11835121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and aldose reductase-inhibitory activities of structural analogues of WF-3681, a novel aldose reductase inhibitor.
    Namiki T; Baba Y; Suzuki Y; Nishikawa M; Sawada K; Itoh Y; Oku T; Kitaura Y; Hashimoto M
    Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1404-14. PubMed ID: 3138031
    [No Abstract]   [Full Text] [Related]  

  • 49. Inhibition of aldose reductase from rat nervous tissue by metabolites of cyclandelate.
    Van den Hoven WE; Hall DW; Burns JW
    Br J Clin Pract Suppl; 1984; 34():31-3. PubMed ID: 6430320
    [No Abstract]   [Full Text] [Related]  

  • 50. In vitro aldose reductase inhibitory activity of substituted N-benzenesulfonylglycine derivatives.
    DeRuiter J; Brubaker AN; Garner MA; Barksdale JM; Mayfield CA
    J Pharm Sci; 1987 Feb; 76(2):149-52. PubMed ID: 3106615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and aldose reductase inhibitory activity of substituted 2-oxoquinoline-1-acetic acid derivatives.
    DeRuiter J; Brubaker AN; Whitmer WL; Stein JL
    J Med Chem; 1986 Oct; 29(10):2024-8. PubMed ID: 3093680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and aldose reductase inhibitory activity of 7-sulfamoylxanthone-2-carboxylic acids.
    Pfister JR; Wymann WE; Mahoney JM; Waterbury LD
    J Med Chem; 1980 Nov; 23(11):1264-7. PubMed ID: 6779009
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S; Kador PF
    Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of aldose reductase inhibitor, CT-112, on sugar alcohol accumulation in corneal epithelium of galactose-fed rats.
    Awata T; Sogo S; Yamamoto Y
    Jpn J Ophthalmol; 1986; 30(3):245-50. PubMed ID: 3097363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and in vitro aldose reductase inhibitory activity of compounds containing an N-acylglycine moiety.
    DeRuiter J; Swearingen BE; Wandrekar V; Mayfield CA
    J Med Chem; 1989 May; 32(5):1033-8. PubMed ID: 2496229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spiro hydantoin aldose reductase inhibitors derived from 8-aza-4-chromanones.
    Sarges R; Goldstein SW; Welch WM; Swindell AC; Siegel TW; Beyer TA
    J Med Chem; 1990 Jul; 33(7):1859-65. PubMed ID: 2113948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N; Tsui J; Johnson M
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of aldose reductases from rat and bovine lenses by flavonoids.
    Okuda J; Miwa I; Inagaki K; Horie T; Nakayama M
    Biochem Pharmacol; 1982 Dec; 31(23):3807-22. PubMed ID: 6818971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats.
    Yoshida T; Nishioka H; Yoshioka K; Nakano K; Kondo M; Terashima H
    Diabetes; 1987 Jan; 36(1):6-13. PubMed ID: 3025043
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isoliquiritigenin: a new aldose reductase inhibitor from glycyrrhizae radix.
    Aida K; Tawata M; Shindo H; Onaya T; Sasaki H; Yamaguchi T; Chin M; Mitsuhashi H
    Planta Med; 1990 Jun; 56(3):254-8. PubMed ID: 2118267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.